sec filing
GR
NASDAQ · GRCE
Grace Therapeutics, Inc.
Healthcare · Biotechnology
$2.12
Down-$0.01 (-0.47%)
Updated Sep 29, 2026, 10:28 PM
SID Score
3.7/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 47.49M
- P/E ratio
- -6.84
- Dividend yield
- 0.00%
- 52-week range
- $1.79 – $5.18
- Volume
- 58.75K
- Avg. volume
- 65.65K
Price performance · GRCE
GRCE price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Sep 28, 2026
GRCE closed at $2.12 after 20 trading sessions, down 0.47% for the selected period.
- Last close
- $2.12
- Period change
- -0.47%
- Period low
- $2.10
- Period high
- $2.29
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 28, 2026 | $2.12 | $2.14 | $2.09 | $2.12 | 58.75K |
| Sep 25, 2026 | $2.14 | $2.14 | $2.10 | $2.12 | 80.18K |
| Sep 24, 2026 | $2.17 | $2.18 | $2.09 | $2.16 | 106.34K |
| Sep 23, 2026 | $2.15 | $2.15 | $2.09 | $2.12 | 193.89K |
| Sep 22, 2026 | $2.09 | $2.165 | $2.08 | $2.14 | 71.12K |
| Sep 21, 2026 | $2.12 | $2.1504 | $2.08 | $2.10 | 109.98K |
| Sep 18, 2026 | $2.14 | $2.17 | $2.10 | $2.11 | 83.72K |
| Sep 17, 2026 | $2.25 | $2.25 | $2.12 | $2.13 | 74.48K |
| Sep 16, 2026 | $2.23 | $2.24 | $2.14 | $2.14 | 65.83K |
| Sep 15, 2026 | $2.29 | $2.29 | $2.17 | $2.23 | 66.2K |
| Sep 14, 2026 | $2.21 | $2.32 | $2.21 | $2.29 | 48.34K |
| Sep 11, 2026 | $2.29 | $2.46 | $2.20 | $2.22 | 716.52K |
| Sep 10, 2026 | $2.24 | $2.31 | $2.20 | $2.26 | 397.54K |
| Sep 9, 2026 | $2.12 | $2.15 | $2.07 | $2.14 | 224.67K |
| Sep 8, 2026 | $2.09 | $2.135 | $2.05 | $2.12 | 159.47K |
| Sep 4, 2026 | $2.12 | $2.1899 | $2.08 | $2.10 | 186.77K |
| Sep 3, 2026 | $2.15 | $2.20 | $2.07 | $2.14 | 159.23K |
| Sep 2, 2026 | $2.19 | $2.19 | $2.0969 | $2.14 | 48.98K |
| Sep 1, 2026 | $2.09 | $2.14 | $2.07 | $2.10 | 78.97K |
| Aug 31, 2026 | $2.1012 | $2.14 | $2.07 | $2.13 | 117.31K |
Latest GRCE news
The latest Smart Investors Daily articles mentioning GRCE.
Stock researchResearch & News · Analysis
Company
OverviewForecastEarnings — requires Earnings Calls and Results accessDividend — requires Dividend Research accessFinancials
Market Activity
OptionsInsider Trades — requires Insider Buying and Selling accessShort InterestInstitutional Ownership — requires Institutional Ownership accessSentiment
Research & News
Loading stock research…